Patent · US Active

Crystalline modifications of N-α-(2,4,6-triisopropyl-phenylsulfonyl)-3-hydroxyamidino-(L)- phenylalanine 4-ethoxycarbonylpiperazide and/or salts thereof

US7713980B2 · kind B2 · utility

7Cited by

0References

19Claims

0Family size

Assignee

Wilex AG · DE

Inventors

Alfons Grunenberg · Wuppertal, DE
Jana Lenz · Wuppertal, DE

Key dates

Filing date	Nov 24, 2005
Grant date	May 11, 2010
Priority date	—
Expiry date	Nov 26, 2026

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D295/185
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to novel crystalline modifications of N-α-(2,4,6-triisopropylphenylsulfonyl)-3-hydroxyamidino-(L)-phenylalanine 4-ethoxycarbonylpiperazide and/or salts thereof, which can be used as pharmaceutical agents, and to pharmaceutical compositions and pharmaceutical uses comprising these novel crystalline modifications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.